Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Total Current Assets Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Total Current Assets
€627.3m
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
46%
Genmab A/S
CSE:GMAB
Total Current Assets
kr21.9B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
23%
Zealand Pharma A/S
CSE:ZEAL
Total Current Assets
kr8.7B
CAGR 3-Years
88%
CAGR 5-Years
41%
CAGR 10-Years
38%
B
Bavarian Nordic A/S
CSE:BAVA
Total Current Assets
kr5.4B
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
23%
F
Fluoguide AS
STO:FLUO
Total Current Assets
kr28.3m
CAGR 3-Years
21%
CAGR 5-Years
227%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Total Current Assets
kr123.9m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
11%

See Also

What is Ascendis Pharma A/S's Total Current Assets?
Total Current Assets
627.3m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Total Current Assets amounts to 627.3m EUR.

What is Ascendis Pharma A/S's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
46%

Over the last year, the Total Current Assets growth was -7%. The average annual Total Current Assets growth rates for Ascendis Pharma A/S have been 2% over the past three years , -2% over the past five years , and 46% over the past ten years .

Back to Top